Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act

Author(s):  Pore R David

Issue:  Nov/Dec 2012 - Volume 16, Number 6
View All Articles in Issue

Page(s):  446-450

Download in electronic PDF format for $65

Abstract:  This article provides a summary of the Drug Enforcement Agency’s current interpretation of the Controlled Substances Act as it relates to the “constructive transfer” of certain controlled substances from pharmacist to physician for office administration. The article discusses compliance with the Controlled Substances Act in this context and related legislative and legal activities of individual pharmacists and of the International Academy of Compounding Pharmacists and other groups.

Related Keywords: R. David Pore, MA, JD, U.S. Drug Enforcement Agency, DEA, constructive transfer, Controlled Substances Act, DEA Form 222, compounded sterile preparations

Related Categories: LEGAL, PAIN MANAGEMENT, PROFESSIONAL ISSUES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details)
Issue/​Page
View/Buy
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act
Pore R David
Nov/Dec 2012
Pg. 446-450

Buy
The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy
Miller David G
Mar/Apr 2012
Pg. 94-96

View Sample
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
Sep/Oct 2021
Pg. 358-362

Buy
Standing Together Fixing the Drug Quality and Security Act
Miller David G
Mar/Apr 2015
Pg. 104-106

Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488

Buy
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Williams LaVonn A
Nov/Dec 2011
Pg. 526-527

Buy
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Miller David G
Sep/Oct 2012
Pg. 382-384

Buy
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications
Gilbert John A
Sep/Oct 2009
Pg. 400-403

Buy
Particle Measuring Systems - USP <797> Environmental Monitoring Solutions